Segments - IV Hydration Therapy Market By Component Type (Medicated and Non-Medicated), By Therapy Type (Hangover Relief, Immune Booster, Energy Booster, Detox Body, Skin Care, Digestion Cure, Others), By End-user (Hospitals, Clinics, Home Settings, and Others), and Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global IV hydration therapy market size was estimated at USD 577.0 Million in 2022 and is anticipated to reach USD 1,026. Million by 2031, expanding at a CAGR of 6.8% during the forecast period, 2023-2031.
Hydration therapy is a type of therapy in which fluids are delivered directly into the bloodstream via a small IV inserted into the arm. IV therapy and hydration are the quickest ways to deliver any type of fluid or medication to the body.
The fluids contain vitamins, electrolytes, antioxidants, and even medication in the mixture. This therapy has also demonstrated many benefits in various fields of healthcare and wellness, with a bioavailability absorption of 100%. It is also used to treat hangovers, migraines, and a variety of other medical conditions. IV hydration therapy is used for various health issues containing:
Dehydration
Electrolyte imbalances
Immunity boosts
Hangover recovery
Low blood pressure
IV hydration therapy is a part of the broader healthcare sector. Healthcare spending in the majority of countries continues to rise across the globe, owing to rising investment in IV hydration therapy. According to the National Health Expenditure Accounts, the US increased by 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of GDP. Increased spending on drug development, solutions, and other drugs is a key factor driving the market.
The COVID-19 pandemic had a positive impact on the Europe IV hydration therapy market due to the use of IV therapies in COVID-19 patients. IV hydration therapy is a treatment used to boost immunity by replenishing it with essential vitamins, antioxidants, and minerals to recover from coronavirus diseases, which is expected to drive market growth.
COVID-19 has resulted in an increased demand for IV hydration therapy in certain conditions. For example, severely ill COVID-19 patients require IV fluids to manage dehydration and maintain electrolyte balance. The admission of COVID-19 patients has put pressure on healthcare facilities and resulted in an increased demand for IV therapy resources. Therefore, the COVID-19 pandemic had a positive impact on the global IV hydration therapy market.
Growing Demand for IV hydration therapy across globally
Increasing demand for IV hydration therapy globally, as it is used to treat a variety of conditions, including dehydration, hangovers, fatigue, and others. IV Infusion Therapy is a safe and effective method of receiving vitamins, minerals, and nutrients that aid in health. The IV drip is administered in less than 30 minutes and provides a peaceful and relaxing experience, which is anticipated to drive the market during the forecast period.
High burden of foodborne illness
There has been an increase in concerns about foodborne illnesses affecting people. Foodborne illnesses including such as food poisoning, diarrhea, and others are expected to fuel the growth of the global IV hydration therapy market over the forecast period.
For example, according to World Health Organization (WHO) data published in June 2019, it is estimated that every minute, 44 people more than 23 million per year become ill from eating contaminated food, and an estimated 4700 deaths in Europe.
The main factors impeding the growth of the Europe IV hydration therapy market are infusion pump accuracy and high infusion pump costs. Pump failures have serious consequences for patient safety due to they are used to deliver high-risk medications. As a result, a lack of accuracy in delivering the fluid limits the market growth. These factors are projected to hinder market expansion.
Increasing awareness and the rising adoption of vitamin IV therapy products are expected to drive market growth during the forecast period. IV hydration therapy is a popular new treatment, and many new facilities have administered it without the medical expertise of a physician.
For instance, research has shown that vitamin C infusions prolong survival times, and improve quality of life, in patients suffering from cancer (NIH), Lyme disease, fibromyalgia, inflammation/inflammatory diseases and conditions chronic migraines, and others.
The report on the global IV Hydration Therapy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
IV Hydration Therapy Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Component Type (Medicated, Non-Medicated), Therapy Type (Hangover Relief, Immune Booster, Energy Booster, Detox Body, Skin Care, Digestion Cure, Others), End-user (Hospitals, Clinics, Home Settings, Others) |
Regional Scope |
Regions (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered |
REVITA; Drip Hydration; CRYOJUVENATE UK LTD; REVIV; Olympia Pharmacy; Soxa Formulations & Research(Pvt.) Ltd; Vitamindrip, Inc.; and Other |
On the basis of Component Type, the market is segmented into medicated and non-medicated. Based on the component, the non-medicated segment held the largest market share of 67.9% in the IV hydration therapy market in 2022, due to the rising demand for therapies in energy-boosting and beauty applications. Furthermore, a constantly growing population has widely adopted IV hydration therapy to keep their skin hydrated and naturally glowing.
Based on therapy type, the market is fragmented into hangover relief, immune booster, energy booster, detox body, skin care, digestion cure, and others. The immune booster segment is held a 21.6% share of the market. The rising demand for IV hydration therapy has emerged as a method to boost an individual's immune system in various health conditions which is anticipated to propel the segment in the coming years.
In terms of the end-user, the market is fragmented into hospitals, clinics, home settings, and others. The hospitals category held a 34.1% share of the market, during the forecast period. These therapies are also offered at a lower cost in hospitals under the supervision of a licensed physician, making it a prime healthcare setting for IV hydration therapy, which is expected to boost segment growth.
Based on regions, the market is separated into namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
For instance, in 2018, REVIV, a company that provides IV therapies and vitamin injections, launched clinics in New York, London, and Hong Kong, to expand healthcare services in various regions at the global level. is projected to drive the market globally.
The market in North America is projected to expand at a substantial CAGR during the forecast period. North America is expected to maintain its dominance in the global market during the forecast period, due to an increase in the prevalence of road accidents, a surge in trauma cases, and an increase in government investments in the development of better healthcare facilities and R&D activities. The region has a high disposable income and high patient spending on overall wellness, which is expected to fuel the growth of the region.
The market in Europe is expected to grow rapidly due to key market players' increasing focus on providing mobile IV hydration therapy services and the use of IV hydration therapy in the adult population, which is expected to support market demand. Furthermore, key Europe market players are constantly focusing on introducing newer technologies into the market to meet changing consumer demands, which is expected to drive regional market growth.
In-depth Analysis of the global IV hydration therapy market
Historical, Current, and Projected Market Size in terms of Value
Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
Industry Drivers, Restraints, and Opportunities Covered in the Study
Recent Industry Trends and Developments
Competitive Landscape & Strategies of Key Players
Neutral Perspective on Global IV Hydration Therapy Market Performance
Manufacturers operating in the global IV Hydration Therapy market are REVITA; Drip Hydration; CRYOJUVENATE UK LTD; REVIV; Olympia Pharmacy; Soxa Formulations & Research(Pvt.) Ltd; Vitamindrip, Inc.; and Other.
Market Players are pursuing key strategies such as collaborations, mergers & acquisitions, and geographic expansion where a potential opportunity rises for the global IV Hydration Therapy market.
The base year considered for the Global IV Hydration Therapy Market report is 2022. The complete analysis period is 2016 to 2031, wherein, 2016 to 2021 are the historic years, and the forecast is provided from 2023 to 2031.
In addition to market size (in US$ Million), Company Market Share (in % for the base year 2022), macroeconomic factors, and Market Dynamics.
The global IV Hydration Therapy market was positively impacted by the COVID-19 outbreak. IV hydration therapy, which is expected to drive market growth, is a treatment used to boost immunity by replenishing it with essential vitamins, antioxidants, and minerals to recover from coronavirus diseases. This is expected the market is growing in the future.
Major manufacturers include REVITA; Drip Hydration; CRYOJUVENATE UK LTD; REVIV; and others.
Factors such as healthcare expenditures, and government regulations are analyzed in the final report.
Hospitals and Clinics are the major Route of Administration of the global IV Hydration Therapy market.
According to this Growth Market Reports report, the Global IV Hydration Therapy Market is likely to register a CAGR of 6.8% during the forecast period 2023-2031, with a projected valuation of USD 1,026.4 million by the end of 2031.
Increasing demand for IV hydration therapy globally, and growing emphasis on improving immunity and keeping hydrated skin are the factors expected to drive the market growth during the forecast period.
Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.
Additional company profiles can be provided on request. For a discussion related to the above findings, click Speak to Analyst